Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elobixibat in diabetic patients with chronic constipation
jRCTs031190092Completed
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of elobixibat in chronic constipation, sponsored by EA Pharma Co., Ltd. Primary endpoint: Weekly frequency of spontaneous bowel movement at week 8 vs pre-treatment. Started Nov 2019; status: completed.
02
Drugs
elobixibat
03
Conditions
chronic constipation
Beyond the preview
Go deeper on jRCTs031190092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190092.